IFRX
InflaRx N.V.
NASDAQ: IFRX · HEALTHCARE · BIOTECHNOLOGY
$1.98
+18.56% today
Updated 2026-04-29
Market cap
$116.39M
P/E ratio
—
P/S ratio
3,968.21x
EPS (TTM)
$-0.80
Dividend yield
—
52W range
$1 – $2
Volume
0.8M
InflaRx N.V. (IFRX) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item |
|---|
| Total assets |
| Cash & equivalents |
| Current assets |
| Total liabilities |
| Current liabilities |
| Long-term debt |
| Shareholder equity |
| Retained earnings |
| Accounts receivable |
| Inventory |
| Goodwill |